Insights

Benchmark International Facilitated the Transaction Between Gem Drugs, Inc. and Vital Care Infusion Services

January 25, 2023

Benchmark International is pleased to announce the transaction between Gem Drugs, Inc. and Vital Care Infusion Services. The reason for targeting was strategic expansion.

Founded in 1976, Gem Drugs is a provider of home infusion therapy services to the Reserve, Louisiana community, and surrounding area. Customers for years have trusted the business of providing in-home IVIG services as a much more convenient option than inpatient care.

For more than 35 years, Vital Care has been dedicated to expanding access to high-quality infusion therapy and driving better patient outcomes by providing local, safe, convenient, and professional infusion services. They are a franchisor to other IVIG providers in the southern US. The Vital Care network spans the country and is comprised of over 65 infusion pharmacy franchises dedicated to providing high-quality, safe, convenient, cost-effective infusion therapy services for chronic and acute patients at a local level. Through Vital Care’s streamlined, proprietary process and best-in-class support, pharmacies can thrive while focusing on what matters most, the patient. 

The synergies between the two parties were obvious. Both seller and buyer were fully familiar with each other’s systems. This allowed for an easier-than-usual process when it came to integration.

Benchmark International brought multiple buyers to the table – ultimately resulting in a great offer. Through a lengthy diligence period and a few hurdles that came up, both parties worked diligently to get the deal across the finish line. In the end, both parties were thrilled with the transaction and looked forward to their continued success.

 

 

 

Share This Post
Ready to dive into our featured M&A content and gain valuable insights for your business?